Dendritic Cell Autophagy Contributes to Herpes Simplex Virus-Driven Stromal Keratitis and Immunopathology by Jiang, Yike et al.
Dartmouth College
Dartmouth Digital Commons
Open Dartmouth: Faculty Open Access Articles
10-27-2015
Dendritic Cell Autophagy Contributes to Herpes










Follow this and additional works at: https://digitalcommons.dartmouth.edu/facoa
Part of the Medical Immunology Commons
This Article is brought to you for free and open access by Dartmouth Digital Commons. It has been accepted for inclusion in Open Dartmouth: Faculty
Open Access Articles by an authorized administrator of Dartmouth Digital Commons. For more information, please contact
dartmouthdigitalcommons@groups.dartmouth.edu.
Recommended Citation
Jiang, Yike; Yin, Xiaotang; Stuart, Patrick M.; and Leib, David A., "Dendritic Cell Autophagy Contributes to Herpes Simplex Virus-
Driven Stromal Keratitis and Immunopathology" (2015). Open Dartmouth: Faculty Open Access Articles. 2623.
https://digitalcommons.dartmouth.edu/facoa/2623
Dendritic Cell Autophagy Contributes to Herpes Simplex Virus-
Driven Stromal Keratitis and Immunopathology
Yike Jiang,a Xiaotang Yin,b Patrick M. Stuart,b David A. Leiba
Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USAa; Department of Ophthalmology, Saint Louis
University, St. Louis, Missouri, USAb
ABSTRACT Herpetic stromal keratitis (HSK) is a blinding ocular disease that is initiated by HSV-1 and characterized by chronic
inflammation in the cornea. Although HSK immunopathology of the cornea is well documented in animal models, events pre-
ceding this abnormal inflammatory cascade are poorly understood. In this study, we have examined the activation of pathologi-
cal CD4 T cells in the development of HSK. Dendritic cell autophagy (DC-autophagy) is an important pathway regulating ma-
jor histocompatibility complex class II (MHCII)-dependent antigen presentation and proper CD4 T cell activation during
infectious diseases. Using DC-autophagy-deficient mice, we found that DC-autophagy significantly and specifically contributes
to HSK disease without impacting early innate immune infiltration, viral clearance, or host survival. Instead, the observed phe-
notype was attributable to the abrogated activation of CD4 T cells and reduced inflammation in HSK lesions. We conclude that
DC-autophagy is an important contributor to primary HSK immunopathology upstream of CD4 T cell activation.
IMPORTANCE Herpetic stromal keratitis (HSK) is the leading cause of infectious blindness in the United States and a rising cause
worldwide. HSK is induced by herpes simplex virus 1 but is considered a disease of inappropriately sustained inflammation
driven by CD4 T cells. In this study, we investigated whether pathways preceding CD4 T cell activation affect disease out-
come.We found that autophagy in dendritic cells significantly contributed to the incidence of HSK. Dendritic cell autophagy did
not alter immune control of the virus or neurological disease but specifically augmented CD4 T cell activation and pathological
corneal inflammation. This study broadens our understanding of the immunopathology that drives HSK and implicates the au-
tophagy pathway as a new target for therapeutic intervention against this incurable form of infectious blindness.
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Herpes simplex virus 1 (HSV-1) is the leading cause of infec-tious blindness in developed countries and a rising cause of
visual impairment worldwide (1, 2). One form of HSV ocular
disease, herpetic stromal keratitis (HSK), is an inflammatory dis-
ease of the cornea characterized by corneal opacity and neovascu-
larization. Due to the incurable and reactivating nature of HSV,
recurrence of HSK approaches 40% after 5 years from initial pre-
sentation (1, 3–6). While HSK is induced by HSV infection, the
inflammatory response is sustained long after clearance of repli-
cating virus (7–10) and is ultimately responsible for the tissue
damage that leads to loss of visual acuity. As a result, supplement-
ing antivirals with topical corticosteroids significantly shortens
the duration of HSK and is the current standard of care (11).
Topical steroids, however, nonspecifically suppress the immune
response and have significant ocular side effects such as cataracts
and glaucoma (12). Development of future therapies depends on
continued study ofHSKpathogenesis and exposing targetable im-
munomodulatory pathways specific to this disease.
Studies in a variety of animal models have elucidated the se-
quence of events that lead to HSK. During the preclinical phase,
HSV-1 infection of the corneal epithelium leads to a productive
initial influx of myeloid cells that limit viral growth (13, 14). After
clearance of infectious virus, however, there is a second chronic
leukocytic infiltration driven by CD4 T cells that coincides with
clinical disease (7, 15). The persistent immune cells, inflammatory
cytokines, lymphangiogenesis (16, 17), and angiogenesis perpet-
uate the chronic tissue damage, compromising corneal integrity
and function. Canonically, the destructive inflammation charac-
terizing HSK is regulated by CD4 T cells (18–21). These patho-
logical CD4 T cells are skewed toward inflammatory Th1 (22)
andTh17 (23) subsets. Consequently, corneal interleukin-2 (IL-2)
(9, 24), gamma interferon (IFN-) (9, 25), and IL-17 (26) are
important mediators of disease. Anti-inflammatory T-regulatory
cells (Tregs), however, are also present on the ocular surface and
serve a protective role against HSK (27–29). In addition, it has
been suggested that virus-specific CD4 T cells are important for
the control of acute infection and maintenance of HSV latency in
neurological tissue (30, 31). Therefore, reducing the levels of
CD4T cells to alleviate HSKmay exacerbate the overall patho-
genesis of HSV (32). An alternative strategy, therefore, might
be to modulate the activation of CD4 T cells to specifically
ameliorate HSK.
Upstream of CD4 T cell activation, dendritic cells (DCs) are
the most potent professional antigen-presenting cell. Present in
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most tissues, including the cornea (33, 34), DCs are important for
both innate and adaptive immunity, and manipulating their abil-
ities may coordinate significant changes in the immune response
and disease pathogenesis. Previous studies show that autophagy in
DCs (DC-autophagy) is a nonclassical pathway for antigen pro-
cessing and presentation on major histocompatibility complex
class II (MHCII) (35, 36). Consistent with these findings, manip-
ulating DC-autophagy alters CD4 T cell activation and the out-
come of HSV-2 genital disease (37), respiratory syncytial virus
(RSV)-induced respiratory disease (38), and experimental auto-
immune encephalomyelitis (EAE) (39). In this study, we examine
the impact of DC-autophagy on HSV-1 pathogenesis. We show
that mice lacking DC-autophagy exhibit abrogated activation of
CD4 T cells, limited corneal inflammation in HSK lesions, and
reduced clinical disease. This phenotype is independent of early
corneal immune infiltration and viral growth, and there are no
changes in overall survival following ocular challenge. Taken to-
gether, our data provide in vivo evidence for the pathological role
of DC-autophagy in orchestrating primary HSK immunopathol-
ogy and point toward a new possible avenue of therapeutic inter-
vention for this blinding disease.
RESULTS
DC-autophagy contributes toHSKdisease. In dendritic cells, au-
tophagy is important for delivery and processing of antigens in the
MHCII antigen presentation pathway and thereby promoting the
activation of CD4 T cells (36, 37). Since HSK is driven by CD4
T cells, we hypothesized that DC-autophagy would contribute to
HSK. To address this, we generated atg5fl/fl CD11c-cre (referred to
in this text as DC-autophagy/) mice. atg5 is considered an es-
sential autophagy and is necessary for the conversion of LC3,
which forms the membrane of the autophagosome (40–42). Off-
spring were fully viable, and we validated the tissue-specific dele-
tion of autophagy in genotyped mice by immunoblotting.
CD11c bone marrow-derived DCs from DC-autophagy/
mice showed reduced levels of atg5, reduced conversion of LC3-I
to LC3-II, and increased accumulation of p62 relative to cells from
atg5fl/fl control mice (see Fig. S1A in the supplemental material).
In comparison, levels of these autophagy proteins were unaltered
inCD11cperitonealmacrophages. In addition, the numbers and
percentages of DCs in the spleen were unaltered in DC-au-
tophagy/ mice relative to controls (see Fig. S1B). Using these
mice, we addressed whether the pathogenesis of HSK was altered.
We infectedDC-autophagy/mice unilaterally withHSV-1, and
disease was imaged and scored by a masked observer for corneal
opacity and neovascularization. While DC-autophagy/ mice
consistently showed reduced corneal opacity (Fig. 1A) and neo-
vascularization (Fig. 1B), neither parameter achieved statistical
significance. However, these mice exhibited a significantly lower
incidence of disease at the end of the 2nd week, the peak of HSK
FIG 1 HSK disease is attenuated in the absence of DC-autophagy. atg5fl/fl
(n  13) and atg5fl/fl CD11c-cre (n  12) female mice were challenged with
2 106 PFU of HSV-1 (strain 17) unilaterally. (A) Corneal opacity was scored
on a scale of 0 to 5. (B) Neovascularization was scored on a scale of 0 to 12. (C)
Positive HSK disease was defined as a corneal opacity score of 1.5 and a
neovascularization score of 2. (D) Summation of 2 other independent ex-
periments showing incidences at 14 dpi of positive (black) and negative (gray)
disease. Error bars represent standard errors of the means. Statistical signifi-
cance was determined by unpaired parametric t test (A and B) and chi-square
test (C and D). *, P 0.05; **, P 0.005.
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severity, than did the atg5fl/fl control mice (Fig. 1C, P  0.0286;
Fig. 1D, P 0.0017).
Since MHCII is downstream of DC-autophagy, we further
confirmed our findings in MHCII/ mice. Compared to con-
trols, the MHCII/ mice had reduced corneal opacity (see
Fig. S2A in the supplemental material) and neovascularization
(see Fig. S2B), but again, neither parameter achieved statistical
significance. However, the MHCII/ mice had significantly
lower disease incidence (see Fig. S2C) at 11 and 32 days postinfec-
tion (dpi) (11 dpi,P 0.0427; 32 dpi,P 0.0241). This deficiency
in antigen presentation was not accompanied by changes in the
viral replication on the corneal surface (see Fig. S2D). Overall,
these data suggest that MHCII-dependent antigen presentation
and DC-autophagy contribute to the incidence of HSK.
DC-autophagy does not impact viral replication or host sur-
vival following peripheral infection with neuroinvasive HSV-1.
Previous work by Lee et al. has shown that mice with defects in
DC-autophagy succumb more rapidly to genital HSV-2 infection
(37). We therefore investigated whether DC-autophagy played a
role in determining survival of ocular HSV-1 infection. After cor-
neal challenge with a neurovirulent strain of HSV-1 (McKrae),
DC-autophagy/ mice and control mice exhibited comparable
neurologic symptoms (see Fig. S3 in the supplemental material)
and rates of mortality within a 21-day experimental period
(Fig. 2A; P 0.45). This phenotypewas consistentwith the similar
viral titers observed in trigeminal ganglia and brains (Fig. 2B to
D). These data suggest thatDC-autophagy has only aminimal role
in the control of neurological spread and growth of HSV-1 or
survival of central nervous system (CNS) infection. Therefore,
DC-autophagy seems to play a specific role in contributing toHSK
pathogenesis.
DC-autophagy does not alter early immune infiltration and
control of viral replication in the cornea. To investigate further
how DC-autophagy contributes to HSK disease, we evaluated pa-
rameters that have been shown to be involved in HSK pathogen-
esis. Since early immune control of viral burden in the cornea is
protective against HSK (43, 44), we hypothesized that the attenu-
ated HSK phenotype observed in DC-autophagy/mice may be
due to greater early immune infiltration and suppression of viral
growth. Three days post-corneal infection with HSV-1, we exam-
ined early myeloid infiltration by flow cytometry (Fig. 3A). Sur-
prisingly, we saw no differences in neutrophil (CD11b Ly6G
Ly6Clow), macrophage (CD11b Ly6G Ly6C or CD11b
Ly6G Ly6Chigh) (45), or overall myeloid (CD11b) infiltration
into the cornea (Fig. 3B). This was consistent, however, with the
comparable levels of viral replication in corneas at 3 and 5 dpi in
DC-autophagy/ and control mice (Fig. 3C). Furthermore, in-
fectious particles in both DC-autophagy/ and control mice be-
came undetectable after 7 dpi, prior to the onset of HSK. Taken
together, these data further support the idea that antigen presen-
tation pathways donotmodulate acute control of viral growth and
that DC-autophagy does not alter early preclinical events in the
cornea leading to HSK disease.
FIG 2 DC-autophagy does not alter survival or neurological viral spread after acute corneal challenge with HSV-1. (A) Attainment of endpoint survival criteria
of atg5fl/fl CD11-cre/DC-autophagy/ (n 49) and atg5fl/fl (n 31) mice after bilateral corneal infection with 2 106 PFU of HSV-1 (McKrae) per eye. Data
are a summation of 5 independent experiments. (B toD)Viral titers in trigeminal ganglia (B), brainstem and cerebellum (C), and cerebrum (D) of C57BL/6 (n
7) and atg5fl/fl CD11-cre (n 7) mice after HSV-1 (McKrae) corneal infection. Data represent 2 to 3 independent experiments. The dotted line marks the limit
of detection. Statistical significance was determined by log rank test (A) and unpaired parametric t test (B to D).
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DC-autophagy is important for activation of CD4T cells in
vivo. Previous reports show that CD4 T cell activation is en-
hanced byDC-autophagy (37, 38, 46, 47). In turn, activatedCD4
T cells and their associated cytokines IFN- and IL-2 contribute to
HSK incidence and persistence (9, 32). Together, these observa-
tions provide a likely explanation for the reducedHSKobserved in
the DC-autophagy/ mice (Fig. 2). To assess this, we evaluated
expression of the early activationmarker CD69 onCD4T cells in
the draining lymph nodes of DC-autophagy/ and control mice
3 days after corneal HSV-1 challenge (Fig. 4A).We found a signif-
FIG 3 DC-autophagy does not alter preclinical myeloid infiltration or viral growth in the cornea. atg5fl/fl CD11-cre (n  10) and atg5fl/fl (n  7) mice were
infected bilaterally with 2 106 PFU per eye of HSV-1 (strain 17). (A and B) Corneas were harvested at 3 dpi and analyzed using flow cytometry for all myeloid
cells (CD11b), neutrophils (CD11b Ly6G Ly6Clow), ormacrophages (CD11b Ly6G Ly6C orCD11b Ly6G Ly6Chigh) (A) and quantified as percentage
of cells (left) and total number of cells per cornea (right) (B). Data represent 3 independent experiments. (C) Viral titers of ocular tear film after challenge with
2 106 PFU of HSV-1 (strain 17) in one eye. Data represent 5 similar experiments. Statistical significance was determined by unpaired parametric t test (B) and
analysis of variance (C).
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icant reduction in the percentage of CD69 cells in the CD4 T
cell compartment of DC-autophagy/ mice relative to control
mice (Fig. 4B; P 0.0053). This is consistent with the hypothesis
that DC-autophagy is important for maximal activation of CD4
T cells and for the promotion of HSK.
DC-autophagy promotes immunopathology inHSK lesions.
Based on the attenuated CD4 T cell activation in DC-au-
tophagy/mice, we hypothesized that the differences in clinical
HSKwere due to reduced CD4T cell infiltration into the cornea.
To test this, we evaluated immune infiltration into corneas at 14
dpi and 38 dpi using flow cytometry (Fig. 5). Although no differ-
ences in the relative proportions of the analyzed cells infiltrating
the cornea were observed at 14 dpi, we found a significant reduc-
tion in the number of CD45 cells (Fig. 5A; P 0.037) and CD4
T cells (Fig. 5E; P  0.044) in the corneas of DC-autophagy/
mice relative to control mice. In DC-autophagy/mice, we also
observed a reproducible but statistically nonsignificant decrease
in the numbers of CD11b GR1 neutrophils and macrophages
(Fig. 5C; P  0.08), which made up a large proportion of the
CD45 immune infiltrate. In contrast, we found no differences in
the numbers of CD11b GR1myeloid cells (Fig. 5B; P 0.20),
CD11c dendritic cells (Fig. 5D; P  0.75), or CD8 T cells
(Fig. 5F; P  0.32). Any differences in immune infiltration were
transient and became blunted by 38 dpi (Fig. 5G to L), which
mirrors disease recovery after 15 dpi (Fig. 1). At 38 dpi, there were
no significant differences in numbers of immune cells between the
floxed control and DC-autophagy/ mice, even though we ob-
served a reduction in the frequency of CD4 (Fig. 5K; P 0.021)
and CD8 (Fig. 5L; P 0.026) T cells in the cornea. This discrep-
ancy in percentage but not absolute number might indicate cor-
neal thinning, a well-documented sequela of HSK (48, 49), which
would cause a greater loss of total corneal cell number in themore
severely diseased control mice.
To further analyze these immunological differences at 14 dpi,
we measured cytokine levels in the cornea with a Luminex cyto-
kine array. Notably, we observed significantly reduced levels of
IL-2 and skewing away from Th1 cytokines in the cornea of DC-
autophagy/ mice relative to control mice (Fig. 6A), consistent
with the reduced number of CD4 T cells (Fig. 5E). We also ob-
served significant reductions in proinflammatory cytokines IL-1
and IL-6 (Fig. 6B); chemokines monocyte chemoattractant pro-
tein 1 (MCP-1)/CCL2, LIX/CXCL5, and IP-10/CXCL10 (Fig. 6C);
and leukemia inhibitory factor (LIF) (Fig. 6D). Additionally, we
also observed nonsignificant but trending decreases (P 0.10) in
IL-12p40 (Fig. 6B); KC/CXCL1, MIP-1/CCL4, and RANTES/
CCL5 (Fig. 6C); and granulocyte colony-stimulating factor (G-
CSF) and vascular endothelial growth factor (VEGF) (Fig. 6D).
Overall, the pathological cytokine signature produced in the cor-
nea of DC-autophagy/ mice after HSK onset was significantly
attenuated. Taken together, we conclude that DC-autophagy me-
diates CD4 T cell activation and infiltration into HSK lesions,
driving pathological inflammation and exacerbating corneal dis-
ease.
DISCUSSION
Dendritic cells are important determinants of HSV-1 pathogene-
sis (43, 50–52). Ablation of the CD11c cells prior to HSV-1 in-
fection promotes greater neurological spread (50) and corneal
replication of the virus (43), while also influencing subsequent
adaptive immune responses (50, 53). Here, we show that the in-
nate and adaptive functions of dendritic cells have differential
requirements for autophagy, thereby specifically limiting HSK
pathogenesis.
Our study shows that DC-autophagy has limited or no effect
on innate immunity and viral growth, which directly impact host
mortality. While previous work showed that DCs control viral
growth through natural killer cell activation (50) and recruitment
(43), we observed no changes in myeloid cell recruitment or viral
titers in the cornea in the DC-autophagy/ mice. Our findings,
FIG 4 DC-autophagy promotes early activation of CD4 T cells after HSV-1
infection. atg5fl/fl CD11-cre (n 11) and atg5fl/fl (n 10) mice were infected
bilaterally with 2 106 PFU per eye, and draining cervical lymph nodes were
harvested at 3 days postinfection and analyzed using flow cytometry. Using the
gating scheme (A), the percentage of CD69 cells in the CD4T cell compart-
ment was quantified (B). Data represent 2 independent experiments. Error
bars represent standard errors of the means. Significance was determined by
unpaired parametric t test. *, P 0.05.
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however, are consistent with the previous observation that au-
tophagy does not alter the ability of DCs to mature, phagocytize,
migrate, or produce innate cytokines (37). Therefore, we reason
that mortality following ocular challenge is unaltered in the ab-
sence of DC-autophagy because innate immune control of viral
replication, a key determinant of neuropathogenesis (54–58), re-
mains intact.
Consistent with previous reports (37–39, 47), we found that
DC-autophagy has a significant impact on the development of
adaptive immunity, specifically CD4 T cell responses. DC-
autophagy was also reported to promote host survival following
intravaginal infection withHSV-2 (37). In our study, however, we
saw no significant changes in viral titers or survival following oc-
ular infection with neurovirulent HSV-1. This contrast in survival
data is most likely due to altered viral spread and tropism follow-
ing use of disparate viruses and routes of infection. Intravaginal
HSV-2 affects the genital mucosal and epidermis, spreading
through the dorsal root ganglia to the spinal cord and pelvic au-
tonomic ganglia, leading to encephalitis and urinary/fecal reten-
tion, respectively (59, 60). Conversely, ocular HSV-1 infection is
limited to the orofacial region and its innervating trigeminal and
autonomic pathways (61), leading to mortality from CNS pathol-
ogy (62). Differences at these mucosal sites and specific routes of
neurological spread likely require different immune components
for control of the virus and downstream pathology. Additionally,
HSV-2 is generally more virulent than HSV-1 regardless of the
route of infection (63). Taken together, the impact of DC-
autophagy on pathogenesis is likely pathogen and disease specific.
The major finding that we report in this study is that DC-
autophagy is a pathological contributor toHSK disease. This find-
ing is consistent with HSK being a chronic human disease with
known pathological involvement of host immunity (11), and the
immunological findings are consistent with the well-supported
paradigm thatHSK is aCD4T cell-driven disease (7–10). Robust
viral replication in the cornea is necessary for adaptive immune
priming and subsequent induction of HSK (64). HSV replication
and HSK are therefore positively correlated. In this study, we
showed modest but reproducibly increased corneal viral titers in
DC-autophagy/mice and yet a reduced incidence of HSK. This
strongly supports the idea that ablation of DC-autophagy can spe-
cifically reduce HSK immunopathology, even with increased viral
loads. Furthermore, our findings recapitulate the attenuated HSK
seen in CD4/ and CD4-depleted mice (32, 65), but we did not
see the reported transient corneal pathologymediated by the com-
pensatory infiltration of CD8 T cells (32). This difference could
simply result from different virus and mouse strains used in this
study (10). Alternatively, these disparate findings could be due to
the role of DC-autophagy in cross-presentation to CD8 T cells,
which is dependent on both the type of dendritic cell and the type
of antigen (66, 67). It could also be due to anti-inflammatory
functions of Tregs (27, 68), which have been shown to reduceHSK
severity (29) and would not be depleted in our study. Further-
more, the pattern and concentrations of IL-10 in the cornea donot
suggest that DC-autophagy exerts its inflammatory effects
through suppression of Tregs. That said, unlike CD4-ablated
mice, the baseline presence of Tregs in DC-autophagy/ mice
likely exerts overall immune suppression. Given these reasons,
our data suggest that DC-autophagy can impact CD4 T cell ac-
tivation and HSK pathogenesis without compensatory CD8 T
cell infiltration into the cornea.
As a result of reduced CD4 T cell activation, DC-au-
tophagy/mice showed overall dampening of immune infiltra-
tion and cytokine production in the cornea. Notably, we saw a
significant reduction in the amount of CD4 T cells and IL-2 in
the cornea. This is consistent with the report that IL-2 promotes
HSK (9) and that anti-IL-2 antibody complexes alleviated HSK
severity (69). We also observed significant differences in proin-
flammatory cytokines (IL-6, IL-1, and MCP-1) previously re-
ported in HSK lesions (17, 70–72) and an overall reduction in
infiltrating immune cells. Neutrophils are the predominant im-
mune cell in HSK lesions (73, 74), and we saw a trending reduc-
tion in the number of CD11b GR1 cells in the HSK lesions of
DC-autophagy/ mice. DC-autophagy is most likely acting on
neutrophils indirectly through activation of CD4 T cells, which
are known to produce cytokines that potentiate neutrophil che-
motaxis and survival in the cornea (24, 73, 75). Considering that
neutrophils are responsible for much of the pathology in the cor-
nea (73, 74, 76), the reduction in clinical disease seen in DC-
autophagy/mice ismost directly attributable to the diminished
neutrophil numbers inHSK lesions.We also observed a reduction
in CXCL10, which was previously reported to augment HSK (44).
Those authors showed that CXCL10/ mice had reduced infil-
tration of neutrophils at the preclinical stage, thereby interfering
with viral clearance and aggravating HSK. Since we observed no
differences in earlymyeloid infiltration or viral clearance, we spec-
ulate that the absence of DC-autophagy alters CXCL10 and neu-
trophil infiltration only during the later time points following vi-
ral clearance. Given that we see immunological differences in the
cornea only during clinical but not at preclinical time points, we
conclude that the immunomodulatory effects of DC-autophagy
have a temporal specificity that is evident in the cornea only dur-
ing HSK.
An important caveat of our approach is that we studied HSK
following primary HSV-1 infection. While many other studies
have used this approach (reviewed in reference 53), it is important
to note that most human cases of HSK are recurrences caused by
reactivating virus (5, 77). That said, it is notable that depletion of
DCs after induction of HSK does not alter disease outcome (53),
suggesting that the signature of a pathological immune response
determined by dendritic cells occurs early during infection, likely
prior to the onset of disease. This may have utility for vaccine
design, sincemodulatingDC-autophagy duringHSV vaccination,
either by engineering the virus or by modulating the host re-
sponse, may fine-tune the CD4 T cell response away from pro-
moting HSK immunopathology while retaining the immune con-
trol of viral growth.
FIG 5 DC-autophagy contributes to immune infiltration into the cornea during HSK. atg5fl/fl and atg5fl/fl CD11c-cre female mice were challenged with 2 
106 PFU of HSV-1 (strain 17) unilaterally. Corneas were analyzed by flow cytometry at 14 dpi (A to F; n 7 per group) and 38 dpi (G to L; n 11 per group).
Samples were first gated on CD45 cells before gating on subpopulations. In each panel, quantification of each cell subset is presented as percentage (left) and
total number (right) in the cornea. Cell populations analyzed include CD45 immune cells (A and G), CD11bGR1 neutrophils and macrophages (C and I),
CD11b GR1 myeloid cells (B and H), CD11c dendritic cells (D and J), CD4 T cells (E and K), and CD8 T cells (F and L). Statistical significance was
determined by unpaired parametric t test. *, P 0.05.
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We have previously reported that HSV-1 34.5 can limit mat-
uration of autophagosomes in dendritic cells, thereby attenuating
activation of CD4 T cells (46). In fact, this is one of three known
mechanisms by which HSV-1 hinders MHCII antigen presenta-
tion (36, 78). This study reveals the intriguing possibility that such
viral blockade of antigen presentation actually leads to reduced
HSK. Immune modulation has largely been viewed as a pathway
for pathogens to cause increased levels of disease. Teleologically,
however, such modulation may also be advantageous to the
pathogen in minimizing immune system-mediated damage and
promoting the success of its host, thereby maximizing the proba-
bility of spread within the host population.
In conclusion, we have shown in this study that autophagy in
dendritic cells is a pathological host factor that contributes to
CD4 T cell-driven HSK without perturbing innate immunity or
control of viral replication. The specificity of this effect and the
expanding repertoire of autophagy modulating drugs (reviewed
in reference 57) make DC-autophagy an attractive candidate for
therapeutic intervention, warranting further investigation.
MATERIALS AND METHODS
Cells and virus. Viruses used in this study were strain 17syn and McK-
rae. Their titers were determined, and they were propagated on African
green monkey kidney (Vero) cells (79–81).
Mice. In all experiments, 6- to 10-week-old mice were used. atg5fl/fl
mice (82) were a generous gift from Skip Virgin (Washington University,
St Louis, MO), and the CD11c-cre mice [strain B6.Cg-Tg(Itgax-cre)1-
1Reiz/J] (83) and MHCII-knockout mice (strain B6.129S2-H2dlAb1-
Ea/J) (84) were purchased from the Jackson Laboratory (Bar Harbor,
ME). The atg5fl/fl and CD11c-cre mice were crossed and bred in-house.
The genetic backgrounds of the progeny mice were assessed at the Dart-
mouth Speed Congenic Core Facility at the Geisel School of Medicine at
Dartmouth (DartMouse). DartMouse uses the Illumina, Inc. (San Diego,
CA), GoldenGate genotyping assay to interrogate 1,449 single-nucleotide
polymorphisms (SNPs) spread throughout the genome. The raw SNP
data were analyzed using DartMouse’s SNaP-Map and Map-Synth soft-
ware, allowing the determination of genetic background at each SNP lo-
cation. Mice were housed in the barrier facility in the Center for Compar-
ative Medicine and Research at the Geisel School of Medicine at
Dartmouth, and all procedures were performed in accordance with fed-
eral and university policies.
Animal procedures. For corneal infections, corneas were scarified
with a 25-gauge needle and inoculated with 2  106 PFU of virus in a
volume of 5 l as previously described (79). For the HSK model, strain
17syn was used unilaterally. Microscopic images of the cornea were
obtained using a Celestron (Torrance, CA) handheld digital microscope,
and images were scored by a masked observer. Corneas were clinically
scored for opacity and neovascularization. As previously described (85),
corneal opacity was evaluated on a scale of 0 to 5, where 0 indicates clear
stroma, 1 indicatesmild stromal opacification, 2 indicatesmoderate opac-
ity, 3 indicates dense opacity, 4 indicates total opacity, and 5 indicates
corneal melt. Corneal neovascularization was evaluated using a scale of 0
to 12, where each of the four quadrants of the eye was evaluated for the
density of new vasculature, also previously described (85). Eye swab ma-
terial was collected, and titers were determined by standard plaque assay
as previously described (86). Brains and trigeminal ganglia were placed in
1.5-ml tubes containing 1-mm-diameter glass beads and 1ml ofmedium.
Sample homogenates were prepared bymechanically disrupting them in a
Mini-Beadbeater-8 (BioSpec Products) and then sonicated. The titers of
homogenates were determined by plaque assay on Vero cells, and the
amount of virus was expressed as PFU permilliliter of tissue homogenate.
For analysis of survival, corneas were infected bilaterally with strainMcK-
rae. Endpoint criteria for sacrificing mice included loss of15% of start-
ing body weight, body temperature loss of 10%, altered locomotion,
and labored breathing.
Tissue preparation for flow cytometry. Eyes were harvested, and cor-
neas were isolated under a dissecting microscope at various times postin-
fection. Corneas were digested in 400 U/ml collagenase II (Life Technol-
ogies) for 1.5 h at 37°C, homogenized with an Eppendorf micropestle,
triturated with a pipettor, and filtered through a 70-mmesh filter before
flow cytometry staining. Cervical lymph nodes were dissected, similarly
homogenized, and filtered before flow cytometry staining. Bloodwas har-
vested by submandibular bleed, and erythrocytes (RBCs) were lysed using
Gey’s solution. The following antibodies were used for flow cytometric
analysis: Ly6G-fluorescein isothiocyanate (FITC) (1A6), CD4-FITC
(GK1.5), CD69-phycoerythrin (PE) (H1.2F3), CD8-PE (53-6.7),
CD11c-FITC (HL3), and GR1-peridinin chlorophyll protein (PerCP)/
Cy5.5 (RB6-8C5), all purchased from BD Biosciences (San Jose, CA).
Ly6C-PerCP/Cy5.5 (HK1.4), CD11b-allophycocyanin (APC) (M1/70),
CD3-PerCP/Cy5.5 (17A2), CD45-APC (30-F11), and CD19-PE (6D5)
were purchased from BioLegend (San Diego, CA), and CD3-APC (17A2)
was purchased from eBioscience (San Diego, CA). Samples were analyzed
using the BD Accuri C6 flow cytometer, and the data were analyzed using
CFlow software (Accuri).
BioPlex multiple cytokine assay. Corneas were harvested from mice
and processed as previously described (87). Corneas were quartered in
150l of phosphate-buffered saline (PBS) plus protease inhibitor (Roche
cOmplete, Mini) and sonicated 6 times for 15 s. After rigorous vortexing,
debriswas spundown and supernatantwas collected for analysis. Amouse
32-plex assay (Millipore) was performed per the manufacturer’s instruc-
tions.
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FIG 6 DC-autophagy contributes to cytokine production in cornea during HSK. Control atg5fl/fl (n 5) and CD11c-cre (n 2) and atg5fl/fl CD11c-cre (n
7) female mice were challenged with 2 106 PFU of HSV-1 (strain 17) unilaterally. Two or three corneas were pooled to make 3 samples per group, which were
analyzed by multiplex protein assay. Cytokines were stratified as T cell cytokines (A), proinflammatory cytokines (B), chemokines (C), and growth factors (D).
We found no detectable amounts of IL-3, IL-4, IL-5, and IL-7 in any of the corneas. Error bars represent standard errors of themeans. Statistical significance was
determined by unpaired parametric t test. *, P 0.05; ND, not detected.
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